Alnylam hypertension drug meets main goal in mid-stage study
Sept 7 (Reuters) - Alnylam Pharmaceuticals said on Thursday its experimental therapy for hypertension met the main goal in a mid-stage study. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)